Why does the government think you’re dead?
Health care is the single largest category in New York State’s budget and has been for years.
And it’s the one area that has had the most uncertainty over the years.
But just because the government says you’re sick doesn’t mean you’re alive.
In fact, the reality of life as a patient is far from clear.
A recent study in the journal Health Affairs looked at how people are treated by hospitals across the state and found that hospitals in rural areas are more likely to take advantage of people who are sick than in larger cities.
“It’s hard to argue that rural hospitals are better places to care for patients with COVID-19,” says David Nettles, a professor of infectious disease at Tufts University and author of “Deadliest Hospitals in America.”
“The vast majority of people that are treated at rural hospitals in New Jersey are not actually in need of hospitalization.”
For one, hospitals often have very limited capacity and have limited beds to treat people.
And rural hospitals don’t usually have much access to the resources needed to help people with COIDs like COVID.
And while the majority of states require people with serious medical conditions to have health insurance, there’s no federal law requiring hospitals to cover the COVID medications.
The National Health Insurance Plan, which covers nearly 20 million people, is the only federal health insurance program that covers the COVEX drug, and it is set to become the only one that covers COVID vaccines.
But it’s unclear how the federal government will cover COVID drugs in rural hospitals.
The U.S. Department of Health and Human Services estimates that COVIDs cost the country as much as $50 billion each year, and many states are looking to expand coverage for the medications.
But the cost of COVID medication can be prohibitively expensive.
The first prescription for COVEYX is $11,000, but that’s about $200 for every person in the U.K. and $200 in the United States.
That’s a cost that could be passed along to hospitals in states like New Jersey, which has a large population of uninsured.
The federal government has pledged $1 billion to cover COVE-19 costs over the next four years, and Nettels said that could cover a lot of rural hospitals’ COVID medicine costs.
But Nettlers says that’s not enough to cover all of the costs associated with treating patients with the disease.
“There’s a lot that needs to be done to provide those kinds of high-quality, compassionate care, but it’s going to take a lot more than that,” Nettls says.
“I think we’re going to see a lot, and I think the government needs to start taking a more aggressive role in that.”
Nettines and his co-authors also found that the cost associated with COVE vaccine administration is higher in states with limited federal funding.
In New Jersey and Vermont, patients with severe respiratory illness are often the first to be given the vaccine, but the cost for administering COVE drugs is much higher in those states, which Nettes says is due to a number of reasons.
For one thing, people in rural New Jersey have fewer doctors and can be much more prone to infection.
“If you’re going into a rural area with no healthcare workers, you’re much more likely than a city person to have an infection,” Nettleles says.
Another issue is that the state is very limited in how many hospitals are equipped to treat patients with respiratory conditions, so the cost can be high.
“The problem is that there are only a couple of hospitals in the state that have that capacity,” Nittles says, “and they’re not doing it for patients who are really sick, but for people who need the medication.”
It’s unclear why hospitals are still struggling to provide a high-standard of care for COVID patients, and some believe it could be due to poor planning and understaffing.
“When I think about how we can have quality, high-value healthcare, I think we need to have quality and we need the best doctors and the best nurses, and we can’t have those two things without a lot better planning,” Nervana Rangappa, executive director of the New Jersey Health Care Foundation, told The Associated Press.
“We need to be able to do everything we can do and get it right the first time.
That doesn’t happen often.”
Rangppa says she’s been advocating for increased funding for healthcare for years and believes that the federal health care law should make sure that states are prepared to provide high-level care to COVID survivors.
“This is a great opportunity to be a part of this effort,” she says.
And that’s exactly what New Jersey is doing.
Nett, the medical director of a hospital in nearby Gloucester, says that he hopes to get the first patients through the hospital’s COVID program in the fall.